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Interstitial and Langerhans’ dendritic 
cells in chronic periodontitis and 
gingivitis
Abstract: The aim of the present study was to compare quantitatively the 
distribution of dendritic cell subpopulations in chronic periodontitis and 
gingivitis. Fourteen biopsies from patients with chronic periodontitis and 
fifteen from patients with gingivitis were studied. An immunoperoxidase 
technique was used to quantify the number of Langerhans’ cells (CD1a) 
and interstitial dendritic cells (factor XIIIa) in the oral and sulcular and 
junctional/pocket epithelia and in the lamina propria. A greater number 
of factor XIIIa+ dendritic cells in the lamina propria and CD1a+ den-
dritic cells in the oral epithelium were observed in gingivitis compared to 
the periodontitis group (p = 0.05). In the sulcular and junctional/pocket 
epithelia and in the lamina propria, the number of CD1a+ dendritic cells 
was similar in the gingivitis and periodontitis groups. In conclusion, the 
number of Langerhans’ cells in the oral epithelium and interstitial den-
dritic cells in the lamina propria is increased in gingivitis compared to 
periodontitis, which may contribute to the different pattern of host re-
sponse in these diseases.
Descriptors: Periodontitis; Gingivitis; Dendritic cells; CD1a; Factor 
XIIIa.
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Introduction
Gingivitis and periodontitis are characterized 
by distinct host responses. Although a great deal 
of information is available, the mechanism which 
regulates this difference is still poorly understood. 
Variation in host response against periodontopatho-
gens is associated with genetics and environmental 
factors;1 however, whether and how gingivitis will 
progress to periodontitis still has to be elucidated. 
It has been suggested that the progression is associ-
ated with more abundant Th2 cells than Th1 cells 
in chronic periodontitis,2 or with an increase in the 
number of B cells and plasma cells in periodontitis 
and predominance of T cells in gingivitis.3
Dendritic cells (DCs) represent a large family of 
antigen-presenting cells that circulate through the 
bloodstream and are scattered in nearly all tissues 
of the body. DCs serve as a connection between 
an innate immune system and an adaptive immune 
response, being the most potent antigen-present-
ing cells. They capture microbes and their antigens 
while in the immature state, and stimulate a T-cell 
response to these antigens in their mature state. DCs 
are the only antigen-presenting cells capable of prim-
ing naive helper/cytotoxic T cells to undergo clonal 
expansion, thus initiating an adaptive immune re-
sponse.4 In their immature state (CD1a positive 
Langerhans’ cells), DCs are efficient antigen capture 
cells and, as they mature, they undergo phenotypic 
changes that facilitate migration toward lymphoid 
organs and enable their ability to prime naive T cells 
in the context of MHC-II molecules.4 Besides stim-
ulating T cell responses, a different subset of DCs 
(factor XIIIa positive interstitial DCs) also directly 
stimulate naive B cells to differentiate into plasma 
cells in vitro.5 
The number of Langerhans’ cells in gingival tis-
sues is a topic of much speculation. Studies have 
reported increased numbers in periodontitis,6 de-
creased numbers in gingivitis and periodontitis 
compared to healthy periodontal tissues,7 and no 
quantitative change in periodontitis compared to gin-
givitis and healthy periodontal tissues.8 On the other 
hand, little is known about the distribution of factor 
XIIIa+ DCs and their possible role in periodontitis 
and gingivitis. Jotwani, Cutler9 (2003), evaluating 7 
biopsies of chronic periodontitis and 5 biopsies of 
healthy gingival tissue, demonstrated that the num-
ber of factor XIIIa+ DCs is increased in periodonti-
tis compared to healthy gingival tissue. 
The present study aimed to compare quantita-
tively the distribution of Langerhans’ cells (CD1a+) 
and interstitial DCs (factor XIIIa+) in chronic peri-
odontitis and gingivitis.
Material and Methods
The study protocol was approved by the Ethics 
Committee, School of Dentistry, University of São 
Paulo, Brazil. 
Biopsies were retrieved from the files of the De-
partment of Oral Pathology, São Leopoldo Man-
dic Dental Research Center, and from those of 
the School of Dentistry, University of São Paulo. 
Fourteen biopsies from cases diagnosed as chronic 
periodontitis (mean age = 34.5 ± 9.2 years; 10 fe-
male and 4 male) and fifteen from cases diagnosed 
as gingivitis (mean age = 32.9 ± 8.9 years; 9 female 
and 6 male), involving systemically healthy patients, 
were analyzed. The diagnoses were obtained based 
on clinical and histological examinations. For his-
tological diagnosis, the sections were stained with 
hematoxylin and eosin.
Serial sections of 3 µm in thickness were ob-
tained from formalin-fixed paraffin-embedded tis-
sue. Dewaxed sections were incubated with primary 
antibody. Clone, pre-treatment for antigen retrieval, 
dilutions, and incubation time are given in Table 1. 
Immunohistochemistry was performed on the sections 
Table 1 - Antibodies, clones, target retrieval, dilutions, incubation times, and cell specificity of the primary antisera.
Antibody Clone Antigen retrieval Dilution Incubation time Cell specificity
CD1a 010* Citrate buffer 0.1 M, 95°C, 30 minutes 1:100 40 minutes Langerhans’ cells
Factor XIIIa Ab-1** No treatment 1:700 40 minutes Interstitial dendritic cells
*Dako Corp., Carpinteria, CA, USA. **Neo Markers, Fremont, CA, USA.
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using the biotin-streptavidin-peroxidase method, fol-
lowed by developing in a diaminobenzidine chromo-
gen solution. Finally, the sections were counterstained 
with Mayer’s hematoxylin. All incubations were per-
formed in a moist chamber at room temperature.
Omission of the primary antibody constituted 
the negative control. For the CD1a antibody, ton-
sil tissue was used as a positive control; for factor 
XIIIa, dermatofibroma was used. 
The specimens were photographed with a micro-
scope (Axioskop 2 Plus, Zeiss, Gottingen, Germany) 
at 400 X magnification interfaced to a computer; 
the areas were delimited with mouse and measured 
with a specific software (Microsoft AxioVision 4.2, 
Carl Zeiss Vision GmbH, Gottingen, Germany). 
Cell counts were performed in duplicate through-
out the entire sections by two masked examiners. 
The number of immunolabeled cells per area unit 
(cell number/mm²) was calculated for each primary 
antibody. Counts of CD1a and factor XIIIa positive 
cells were restricted to immunolabeled cells exhibit-
ing a well-defined cell nucleus and body with at least 
two well-visualized dendrites. Three regions were 
evaluated: oral epithelium, sulcular and junctional/
pocket epithelia, and lamina propria (Figure 1). 
The mean value of the counts of the two examin-
ers was used for statistical analysis. Differences in 
the number of immunolabeled cells between the gin-
givitis and periodontitis groups were analysed using 
the Mann-Whitney U test. Statistical significance 
was defined as p ≤ 0.05. Calculations were per-
formed using a statistical software package (SPSS 
Inc., Chicago, IL, USA). 
Results
Table 2 presents the mean number ± standard 
deviation of CD1a+ and factor XIIIa+ cells/mm² in 
the oral epithelium, junctional/sulcular epithelia, 
and lamina propria in the gingivitis and periodon-
titis groups. 
In the oral epithelium, the number of CD1a+ den-
dritic cells/mm² was significantly greater (p = 0.05) 
in gingivitis than in periodontitis (137.69 ± 90.36 
and 74.09 ± 74.75 respectively) (Figures 2A and 2B). 
In the sulcular and junctional/pocket epithelia and 
lamina propria, the counts of CD1a+ dendritic cells 
were similar in both groups.
A greater number of factor XIIIa+ dendritic 
cells in the lamina propria was observed in gingi-
vitis compared to the periodontits group (p = 0.05) 
(209.49 ± 101.26 and 104.27 ± 95.52, respectively) 
(Figures 2C and 2D). No factor XIIIa+ dendritic cell 
was observed in the epithelia. 
Discussion
The present study reveals significant differences 
in the number of CD1a+ cells/mm² in the oral epi-
thelium and of factor XIIIa+ cells/mm² in the lami-
na propria between periodontitis and gingivitis, be-
ing the numbers increased in gingivitis. 
The lower number of DCs in periodontitis com-
pared to gingivitis may decrease the defense response 
SE
OE
JE
LP
Table 2 - Mean number ± Standard deviation of CD1a+ 
and factor XIIIa+ cells/mm² in the oral epithelium (OE), 
junctional/sulcular epithelia (JE), and lamina propria (LP) in 
the gingivitis and periodontitis groups.
Antibody
Counting 
Zone
Group
Gingivitis
(N = 15)
Periodontitis
(N = 14)
p 
value
CD1a
OE  137.7 ± 90.4  74.1 ± 74.8 0.05
JE 174.3 ± 129.6 116.8 ± 137.9 0.11
LP 259.9 ± 109.8 278.6 ± 180.9 0.86
Factor XIIIa LP 209.5 ± 101.3  104.3 ± 95.5 0.05
Figure 1 - Gingival counting zones: oral epithelium (OE), 
sulcular (SE) and junctional/pocket epithelia (JE), and lamina 
propria (LP). (Immunohistochemistry, CD1a, 100 X).
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to periodontal bacteria, thus explaining the different 
patterns of disease. The differences in the number 
of DCs might be associated with several factors: 1 - 
DC differentiation may be inhibited by certain peri-
odontal bacteria. DC differentiation and maturation 
is inhibited by many infectious agents. It has been 
demonstrated that human monocytes cultured with 
granulocyte-macrophage colony-stimulating factor 
(GM-CSF) and interleukin-4 (IL-4) after phagocy-
tosis of Candida albicans yeast do not differentiate 
into DCs; they retain CD14 expression, do not ac-
quire CD1a expression, and are unable to express the 
maturation markers CD83 and CCR7. On the other 
hand, monocytes that had phagocytosed mycelial 
forms differentiate into mature CD83+ and CCR7+ 
cells.10 Similarly, M. tuberculosis down-regulates 
CD1a expression on DCs,11 and plasmodium infec-
tion is also characterized by inhibition of DC func-
tion in vivo and in vitro.11 2 - DCs have captured the 
antigens and matured. Porphyromonas gingivalis li-
popolysaccharide triggers maturation of DCs,12 thus 
immature DCs (CD1a+) in periodontitis may have 
captured the antigens (Porphyromonas gingivalis) 
and maturated to present the antigens,6 and then a 
lower number of CD1a+ cells was observed in peri-
odontitis. 3 - Patients with periodontitis may present 
a lower differentiation of DCs compared to patients 
with gingivitis, and this may increase the risk of pro-
gression of gingivitis to periodontitis. Further stud-
ies are required to evaluate these hypotheses.
The Langerhans’ cell network seems to change 
markedly with aging13 and smoking habits.14 In this 
study the groups were age-matched. However, the 
information concerning the smoking habits was not 
Figure 2 - CD1a+ dendritic cells in the oral epithelium. A - chronic periodontitis (Immunohistochemistry, 100 X); B - gingivitis 
(Immunohistochemistry, 200 X). In the oral epithelium, the number of CD1a+ dendritic cells/mm² was significantly greater in gin-
givitis than in periodontitis. Factor XIIIa+ dendritic cells in the lamina propria. C - chronic periodontitis (Immunohistochemistry, 
400 X); D - gingivitis (immunohistochemistry, 400 X). A greater number of factor XIIIa+ dendritic cells in the lamina propria was 
observed in gingivitis compared to the periodontitis group. 
A B
C D
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available and further studies are required to assess 
the role of smoking. 
It has been previously reported that although DC 
heterogeneity has been observed in humans, their 
lineage origins, maturation stages and functional 
differences have not been clearly established. Inter-
stitial DCs, also known as dermal DCs, and Lang-
erhans’ cells are originated from a myeloid lineage.15 
They are “immature” cells, i.e., are unable to stimu-
late T cells. Although these DCs lack the requisite 
accessory signals for T-cell activation, such as CD40, 
CD54 and CD86, they are extremely well equipped 
to capture antigens. After antigen capture, full mat-
uration and mobilization of DCs are induced. In the 
epithelium, immature DCs known as Langerhans’ 
cells are labeled for CD1a+. Langerhans’ cells take 
up particles and microbes by phagocytosis,16 mature 
and move into lymphoid tissues17 or lamina propria6 
in search of T cells for antigen presentation.
In the present study, the number of CD1a+ DCs/
mm² in the oral epithelium was significantly higher 
in gingivitis compared to periodontitis. On the other 
hand, in the sulcular and junctional/pocket epithelia 
and lamina propria, the counts of CD1a+ DCs were 
similar in periodontitis and gingivitis. These results 
might be associated with a limited T cell count in 
periodontitis as compared to gingivitis.3 However, 
contrasting results have been shown in the litera-
ture regarding DC counts in periodontal diseases. 
Increased numbers in periodontitis,6 decreased 
numbers in gingivitis and periodontitis compared 
to healthy periodontal tissues,7 and no quantitative 
change in periodontitis compared to gingivitis and 
healthy periodontal tissues8 have been reported. The 
number of DCs changes markedly with aging and 
smoking habits, which may explain such divergent 
results.13,14
Cells that express CD34 contain progenitors for 
two discrete DCs populations: the epidermal Lang-
erhans’ cells and dermal or interstitial type of DCs.5 
Factor XIIIa+ cells represent interstitial DCs4 which 
have major effects on B-cell growth and immuno-
globulin secretion.4 Naïve B cells respond uniquely 
to the interstitial, non-Langerhans’ cell type of DCs, 
and by secretion of soluble factors, the interstitial 
type of DCs stimulate the prodution of antibodies 
directly. One important functional difference be-
tween CD1a+ and factor XIIIa+ cells is that only 
interstitial-type DCs directly stimulate naïve B cells 
to make antibodies.5,18 In the present study, the 
number of factor XIIIa+ cells was greater in gin-
givitis than in periodontitis, indicating that factor 
XIIIa-positive cells may also play an important role 
in the periodontal disease pathogenesis. Jotwani, 
Cutler9 (2003) have shown that the number of factor 
XIIIa+ DCs is increased in periodontitis compared 
to healthy gingival tissue.
Conclusion
In conclusion, the number of Langerhans’ cells in 
the oral epithelium and interstitial DCs in the lam-
ina propria is increased in gingivitis compared to 
periodontitis, which may contribute to the different 
pattern of host response in these diseases. However, 
the immune process is complex, and further studies 
controlling smoking habits and other host variables 
are required to reach a better understanding of the 
role of DCs in periodontal disease. 
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